Managing vesicoureteral reflux in children: Making sense of all the data.

Angelena Edwards, Craig A. Peters

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Current management of vesicoureteral reflux (VUR) in children is the result of a steady albeit controversial evolution of data and thinking related to the clinical impact of VUR and urinary tract infection (UTI) in children, the value of clinical screening, and the relative impact of testing and interventions for VUR. While controversy continues, there is consensus on the importance of bladder dysfunction on VUR outcomes, the likelihood of VUR resolution, and the fact that not all children with VUR require active treatment. Early efforts to define risk stratification hold the most promise to provide more patient-specific treatment of UTI and VUR in children.

Original languageEnglish (US)
Article number29
StatePublished - 2019


  • Antibiotic prophylaxis
  • Pediatric Vesicoureteral Reflux
  • Renal scarring
  • Urinary tract infection

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Immunology and Microbiology
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Managing vesicoureteral reflux in children: Making sense of all the data.'. Together they form a unique fingerprint.

Cite this